Arcus Biosciences Inc (RCUS)

EBITDA Margin

-207.32%

Quarterly · Period ending:

RCUS logo

RCUS EBITDA Margin

Latest reported-207.32%
RCUS Quarterly EBITDA Margin (0.00% → -207.32%)
High-resolution chart · PNG

RCUS ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Arcus Biosciences Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
-207.3171%
-723.5294%
-245.4545%
-500%
2.5%
-385.7143%
-342.3077%
-185.4167%
-233.3333%
0%
-248.3871%
-209.375%
-248.2759%
-300%
-188.5842%
-190.9091%
-237.037%
-366.6667%
80.2251%
-813.9943%
-794.3135%
-758.831%
-529.0608%
3.9547%
-2,539.3143%
-1,566.5143%
-170.9846%
-1,277.8857%
-1,615.8286%
-1,018.2857%
-802.6248%
-260.3356%
-1,198.72%
-1,000.24%
-1,006.24%
-13,743.5583%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.